|
Fusion gene ID: 21727 |
FusionGeneSummary for MET_CAV1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: MET_CAV1 | Fusion gene ID: 21727 | Hgene | Tgene | Gene symbol | MET | CAV1 | Gene ID | 8731 | 857 |
Gene name | RNA guanine-7 methyltransferase | caveolin 1 | |
Synonyms | CMT1|CMT1c|MET|Met|RG7MT1|cm1p|hCMT1|hMet | BSCL3|CGL3|LCCNS|MSTP085|PPH3|VIP21 | |
Cytomap | 18p11.21 | 7q31.2 | |
Type of gene | protein-coding | protein-coding | |
Description | mRNA cap guanine-N7 methyltransferaseRNA (guanine-7-) methyltransferasehcm1pmRNA (guanine-7-)methyltransferasemRNA (guanine-N(7)-)-methyltransferasemRNA cap methyltransferase | caveolin-1caveolin 1, caveolae protein, 22kDacell growth-inhibiting protein 32 | |
Modification date | 20180523 | 20180527 | |
UniProtAcc | P08581 | Q03135 | |
Ensembl transtripts involved in fusion gene | ENST00000397752, ENST00000318493, ENST00000436117, ENST00000495962, ENST00000539704, | ENST00000341049, ENST00000393470, ENST00000405348, ENST00000393468, ENST00000393467, | |
Fusion gene scores | * DoF score | 8 X 7 X 8=448 | 6 X 4 X 6=144 |
# samples | 10 | 8 | |
** MAII score | log2(10/448*10)=-2.16349873228288 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/144*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: MET [Title/Abstract] AND CAV1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | MET | GO:0006370 | 7-methylguanosine mRNA capping | 27422871 |
Tgene | CAV1 | GO:0009617 | response to bacterium | 24625804 |
Tgene | CAV1 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 25893292 |
Tgene | CAV1 | GO:0031295 | T cell costimulation | 17287217 |
Tgene | CAV1 | GO:0031623 | receptor internalization | 25893292 |
Tgene | CAV1 | GO:0032091 | negative regulation of protein binding | 16890161 |
Tgene | CAV1 | GO:0032570 | response to progesterone | 12388746 |
Tgene | CAV1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 18081315 |
Tgene | CAV1 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 18081315 |
Tgene | CAV1 | GO:0043627 | response to estrogen | 12388746 |
Tgene | CAV1 | GO:0051480 | regulation of cytosolic calcium ion concentration | 19052258 |
Tgene | CAV1 | GO:0072584 | caveolin-mediated endocytosis | 19931615 |
Tgene | CAV1 | GO:1900027 | regulation of ruffle assembly | 24625804 |
Tgene | CAV1 | GO:2000535 | regulation of entry of bacterium into host cell | 24625804 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BRCA | TCGA-B6-A0I6-01A | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
TCGA | RV | STAD | TCGA-BR-7716-01A | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
TCGA | RV | UCEC | TCGA-B5-A0JN-01A | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000397752 | ENST00000341049 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
5UTR-3CDS | ENST00000397752 | ENST00000393470 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
5UTR-3CDS | ENST00000397752 | ENST00000405348 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
5UTR-3CDS | ENST00000397752 | ENST00000393468 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
5UTR-3CDS | ENST00000397752 | ENST00000393467 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
5UTR-3CDS | ENST00000318493 | ENST00000341049 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
5UTR-3CDS | ENST00000318493 | ENST00000393470 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
5UTR-3CDS | ENST00000318493 | ENST00000405348 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
5UTR-3CDS | ENST00000318493 | ENST00000393468 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
5UTR-3CDS | ENST00000318493 | ENST00000393467 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000436117 | ENST00000341049 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000436117 | ENST00000393470 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000436117 | ENST00000405348 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000436117 | ENST00000393468 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000436117 | ENST00000393467 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000495962 | ENST00000341049 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000495962 | ENST00000393470 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000495962 | ENST00000405348 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000495962 | ENST00000393468 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000495962 | ENST00000393467 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000341049 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000393470 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000405348 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000393468 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000393467 | MET | chr7 | 116312631 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000397752 | ENST00000341049 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000397752 | ENST00000393470 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000397752 | ENST00000405348 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000397752 | ENST00000393468 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000397752 | ENST00000393467 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000318493 | ENST00000341049 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000318493 | ENST00000393470 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000318493 | ENST00000405348 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000318493 | ENST00000393468 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000318493 | ENST00000393467 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000436117 | ENST00000341049 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000436117 | ENST00000393470 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000436117 | ENST00000405348 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000436117 | ENST00000393468 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000436117 | ENST00000393467 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000495962 | ENST00000341049 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000495962 | ENST00000393470 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000495962 | ENST00000405348 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000495962 | ENST00000393468 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000495962 | ENST00000393467 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000341049 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000393470 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000405348 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000393468 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000393467 | MET | chr7 | 116340338 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000397752 | ENST00000341049 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000397752 | ENST00000393470 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000397752 | ENST00000405348 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000397752 | ENST00000393468 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000397752 | ENST00000393467 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000318493 | ENST00000341049 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000318493 | ENST00000393470 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000318493 | ENST00000405348 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000318493 | ENST00000393468 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000318493 | ENST00000393467 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000436117 | ENST00000341049 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000436117 | ENST00000393470 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000436117 | ENST00000405348 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000436117 | ENST00000393468 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Frame-shift | ENST00000436117 | ENST00000393467 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
3UTR-3CDS | ENST00000495962 | ENST00000341049 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
3UTR-3CDS | ENST00000495962 | ENST00000393470 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
3UTR-3CDS | ENST00000495962 | ENST00000405348 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
3UTR-3CDS | ENST00000495962 | ENST00000393468 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
3UTR-3CDS | ENST00000495962 | ENST00000393467 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000341049 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000393470 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000405348 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000393468 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
intron-3CDS | ENST00000539704 | ENST00000393467 | MET | chr7 | 116381079 | + | CAV1 | chr7 | 116199000 | + |
Top |
FusionProtFeatures for MET_CAV1 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
MET | CAV1 |
Receptor tyrosine kinase that transduces signals fromthe extracellular matrix into the cytoplasm by binding tohepatocyte growth factor/HGF ligand. Regulates many physiologicalprocesses including proliferation, scattering, morphogenesis andsurvival. Ligand binding at the cell surface inducesautophosphorylation of MET on its intracellular domain thatprovides docking sites for downstream signaling molecules.Following activation by ligand, interacts with the PI3-kinasesubunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1.Recruitment of these downstream effectors by MET leads to theactivation of several signaling cascades including the RAS-ERK,PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation isassociated with the morphogenetic effects while PI3K/AKTcoordinates prosurvival effects. During embryonic development, METsignaling plays a role in gastrulation, development and migrationof muscles and neuronal precursors, angiogenesis and kidneyformation. In adults, participates in wound healing as well asorgan regeneration and tissue remodeling. Promotes alsodifferentiation and proliferation of hematopoietic cells. Mayregulate cortical bone osteogenesis (By similarity).{ECO:0000250|UniProtKB:P16056}. Acts as a receptor for Listeria internalin inlB,mediating entry of the pathogen into cells. | May act as a scaffolding protein within caveolarmembranes. Interacts directly with G-protein alpha subunits andcan functionally regulate their activity (By similarity). Involvedin the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Its binding to DPP4 induces T-cellproliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner. Recruits CTNNB1 to caveolar membranes and mayregulate CTNNB1-mediated signaling through the Wnt pathway.Negatively regulates TGFB1-mediated activation of SMAD2/3 bymediating the internalization of TGFBR1 from membrane raftsleading to its subsequent degradation (PubMed:25893292). Mediatesthe recruitment of CAVIN proteins (CAVIN1/2/3/4) to the caveolae(PubMed:19262564). {ECO:0000250|UniProtKB:P49817,ECO:0000269|PubMed:11751885, ECO:0000269|PubMed:17287217,ECO:0000269|PubMed:19262564, ECO:0000269|PubMed:25893292}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for MET_CAV1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for MET_CAV1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
MET | GLMN, CDH1, CTNNB1, HGF, RANBP9, GRB2, CBL, SH3KBP1, RANBP10, SRC, SHC1, SOS1, STAT3, GAB1, GAB2, LRIG1, INPPL1, DCN, SPSB1, SPSB2, SPSB3, SPSB4, CBLC, STUB1, HSPA4, HSP90AA1, GGA3, GNG12, FBXO6, HGS, CRK, CEACAM21, LGALS9, PCBP1, CASP3, SOCS1, HSP90AB1, EGFR, ERBB3, MET, CHEK1, PTEN, SCGB1D1 | CAV1 | AR, SCP2, PLD2, AQP3, EDNRB, NOS3, CAV2, NOS2, BTK, BMX, GRK5, GRK1, ADRBK1, TRAF2, TRADD, TNFRSF1B, TRPC1, NTRK1, NGFR, NEU3, TSC2, DAG1, APP, INSR, PRKACA, PTPN1, PTPN6, PTPN11, PTEN, PTPRF, S1PR1, FLOT1, FLOT2, ESR1, PTGS2, PDGFRB, PDGFRA, RCVRN, CSK, EGFR, SRC, TGFBR1, SMAD2, GJA1, GJB2, GJB1, TNFRSF1A, TNF, NKD2, RAC1, RHOA, RHOC, MAPK3, MAPK1, PLAA, PDIA3, CD44, CXCR4, ITCH, TOLLIP, IRAK1, FYN, KCNA3, KCNA5, PPP1CA, PPP2R1A, PPP2R1B, PPP2CA, PPP2R4, SNCA, PTRF, ACIN1, VDAC1, SQSTM1, VCP, UBXN6, KCNN3, MCL1, ITPR3, PTCH1, TENC1, DLC1, ID1, MLC1, NF1, MALL, KCNMA1, BMPR2, BMPR1A, AXIN1, LRP6, FAS, BID, HSP90AA1, ACTB, F2R, PROCR, GLIPR2, KDR, ATP4A, DERL1, VIMP, UFD1L, PTGS1, PTGIS, RPA3, RPA2, RPA1, ATG5, ATG12, ABCC1, TFRC, MOV10, NXF1, PPARG, LATS1, VAV2, KRT8, PLCG1, CTNNB1, HDAC6, AGTR1, LPAR6, P2RY12, FNDC4, FAF2, FAP, TMEM17, TMEM216, CLTC, DBN1, RAB2A, RAB5C, RAB7A, DYNLL1, VAPA, FGFR1OP2, GOLT1B, LIMA1, TMEM63B, YIPF5, MMGT1, MBOAT1, ANKRD13A, ADCY6, ADCY5, TLR4, YIPF3, SMPD3, SLC22A9, CAV3, TACR1, HK1, LPAR4, SLC5A8, CHRM3, SLC37A3, HTR2C, TMEM184A, SLC6A15, NR3C2, UBC, MAP1LC3A |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MET_CAV1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | MET | P08581 | DB08865 | Crizotinib | Hepatocyte growth factor receptor | small molecule | approved |
Hgene | MET | P08581 | DB08875 | Cabozantinib | Hepatocyte growth factor receptor | small molecule | approved|investigational |
Top |
RelatedDiseases for MET_CAV1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | MET | C1336839 | Type 1 Papillary Renal Cell Carcinoma | 5 | UNIPROT |
Hgene | MET | C0007131 | Non-Small Cell Lung Carcinoma | 4 | CTD_human |
Hgene | MET | C0001418 | Adenocarcinoma | 2 | CTD_human |
Hgene | MET | C0004352 | Autistic Disorder | 2 | CTD_human |
Hgene | MET | C0027627 | Neoplasm Metastasis | 2 | CTD_human |
Hgene | MET | C0038356 | Stomach Neoplasms | 2 | CTD_human |
Hgene | MET | C0004114 | Astrocytoma | 1 | CTD_human |
Hgene | MET | C0007134 | Renal Cell Carcinoma | 1 | CTD_human |
Hgene | MET | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
Hgene | MET | C0009241 | Cognition Disorders | 1 | CTD_human |
Hgene | MET | C0014859 | Esophageal Neoplasms | 1 | CTD_human |
Hgene | MET | C0017636 | Glioblastoma | 1 | CTD_human |
Hgene | MET | C0019189 | Hepatitis, Chronic | 1 | CTD_human |
Hgene | MET | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
Hgene | MET | C0023904 | Liver Neoplasms, Experimental | 1 | CTD_human |
Hgene | MET | C0024121 | Lung Neoplasms | 1 | CTD_human |
Hgene | MET | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | MET | C0027819 | Neuroblastoma | 1 | CTD_human |
Hgene | MET | C0029463 | Osteosarcoma | 1 | CTD_human |
Hgene | MET | C0036341 | Schizophrenia | 1 | CTD_human |
Hgene | MET | C0037199 | Sinusitis | 1 | CTD_human |
Hgene | MET | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Hgene | MET | C0919267 | ovarian neoplasm | 1 | CTD_human |
Hgene | MET | C1876165 | Copper-Overload Cirrhosis | 1 | CTD_human |
Hgene | MET | C2239176 | Liver carcinoma | 1 | CTD_human;HPO;UNIPROT |
Hgene | MET | C4084709 | DEAFNESS, AUTOSOMAL RECESSIVE 97 | 1 | UNIPROT |
Tgene | CAV1 | C1458155 | Mammary Neoplasms | 4 | CTD_human |
Tgene | CAV1 | C0004238 | Atrial Fibrillation | 2 | CTD_human |
Tgene | CAV1 | C0033578 | Prostatic Neoplasms | 2 | CTD_human |
Tgene | CAV1 | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human |
Tgene | CAV1 | C0017612 | Glaucoma, Open-Angle | 1 | CTD_human |
Tgene | CAV1 | C0018800 | Cardiomegaly | 1 | CTD_human |
Tgene | CAV1 | C0020538 | Hypertensive disease | 1 | CTD_human |
Tgene | CAV1 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | CAV1 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Tgene | CAV1 | C0036341 | Schizophrenia | 1 | PSYGENET |
Tgene | CAV1 | C0038325 | Stevens-Johnson Syndrome | 1 | CTD_human |
Tgene | CAV1 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | CAV1 | C0043094 | Weight Gain | 1 | CTD_human |
Tgene | CAV1 | C0271694 | Familial partial lipodystrophy | 1 | CTD_human |
Tgene | CAV1 | C0919267 | ovarian neoplasm | 1 | CTD_human |